Sanofi (SNY): Among the Best International Dividend Stocks to Buy Now
We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...
Zawya5h
Sanofi is transferring its global expertise in insulin production to Saudi Arabia
Saudi Arabia is now shifting toward localized production, a move that will significantly enhance national drug security and ...
Pharma companies turn to AI to speed up drug development, but hit hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
PharmiWeb18h
The 7th CKD Drug Development Summit Returns to Boston to Shape the Future of Renal Therapeutics
The chronic kidney disease drug development landscape is evolving at an unprecedented pace, driven by breakthrough approvals, billion-dollar mergers and acquisitions, and increasing regulatory support ...
Regeneron Pharmaceuticals, Inc.: Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
Daily23h
Sanofi secures approval in India for chronic graft-versus-host disease drug Rezurock
Sanofi Healthcare India Pvt. Limited has announced receipt of marketing authorization for Rezurock (Belumosudil Tablets) in ...
The Pharma Letter23h
BMS’ cancer drug Breyanzi set for another approval
US pharma major Bristol Myers Squibb has announced that the Phase II TRANSCEND FL trial evaluating Breyanzi (lisocabtagene ...